$3.23
-0.015-0.46%
Last update: Nov 11, 4:00 PM
X4 Pharmaceuticals Inc
XFORNASDAQ
X4 Pharmaceuticals fell 8.5% from $3.53 to $3.23, behind the S&P 500's +9.8%. Its worst day was Sep 8 (−13.2%), and its low came Oct 14 at $2.45.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
X4 Pharmaceuticals shares rose 16.9%, while the S&P 500 rose 0.1%.
+16.9% · S&P 500 +0.1%
X4 Pharmaceuticals shares rose 13.9%, while the S&P 500 rose 0.6%.
+13.9% · S&P 500 +0.6%
Story events cover the past 12 months · Times ET
EPS of $-0.22 beat the $-0.35 estimate on $2.6M revenue (est. $1.7M).
+18.8%, the year's best day · S&P 500 +0.3%
EPS of $-0.16 beat the $-0.20 estimate on $2.7M revenue (est. $3.4M).
+4.3% · S&P 500 +1.4%
X4 Pharmaceuticals closed at its highest level of the year, 32.3% above where the year started.
+10.4% · S&P 500 +0.8%
X4 Pharmaceuticals shares rose 11.4%, while the S&P 500 rose 0.4%.
+11.4% · S&P 500 +0.4%
EPS of $-0.13 beat the $-0.19 estimate on $8.8M revenue (est. $2.2M).
+11.3% · S&P 500 +0.6%
X4 Pharmaceuticals shares fell 13.2%, while the S&P 500 fell 0.5%.
−13.2%, the year's worst day · S&P 500 −0.5%
X4 Pharmaceuticals closed at its lowest level of the year, 30.6% below where the year started.
−5.8% · S&P 500 −1.1%
EPS of $-0.16 beat the $-0.19 estimate on $2.9M revenue (est. $2.2M).
+2.2% · S&P 500 +1.7%
Where it ended: a close of $3.23 on Nov 11, 2026.
Nothing in the past 12 months.
All XFOR dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XFOR and SPY from Benzinga historical bars. Not investment advice.
